Antimicrobial Resistance (AMR) is an increasingly wide-scale problem. Not contained by borders, and with the ability to turn minor infections into life threatening conditions, it is an issue that experts argue must be addressed in the present, not the future.
Hear from Jennifer Schneider of Centauri Therapeutics, Franz-Werner Haas of LimmaTech Biologics and Neil Murray of ReNewVax on their unique approaches to tackling the threat of AMR, in the latest episode of the Optimum Perspectives Podcast.
","author_name":"Optimum Strategic Communications"}